| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d1eacfdc39bba34fa2ed5446c83e039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fa987d4d0fe3bc65b14dd0416866d23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_641c7703109768827e2c6d9a146c6b19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea0de26b3bb22f02747a50127aba633 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25d06012ef611d3fdbe65af44231812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d21ee750c064759cba1357b8e5e90e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3367d91ab9bcfbc7b7b24ee2650a14d6 |
| publicationDate |
2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013151627-A1 |
| titleOfInvention |
Methods of treating glucose metabolism disorders |
| abstract |
Methods of treating individuals with a glucose metabolism disorder, and compositions suitable for use in the methods, are provided. As described in the disclosure, peptide subsequences derived from the Tor2a gene product have been identified. More particularly, ten murine peptides (ms p1-ms p10) and ten human peptides (hu p1-hu p10) have been identified (see Figure 2), and these peptides are distinct from the salusin peptides (i.e., neither the murine peptides nor the human peptides overlap with the murine and human amino acid sequences of the salusin peptides. |
| priorityDate |
2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |